International Trial for Lung Cancer Vaccine Begins

Welcome to the Friday edition of Good News. It’s time to shake off the work week and reset! From making progress in a cure for cancer to experts finding water on the Moon, get ready to start the weekend on a high note! Enjoy!

• 🧬 International Trial for Lung Cancer Vaccine Begins

• 🦁 Berlin Panda Gives Birth to Twins - Again!

• 🚀 Scientists Found a Method to Extract Water from Lunar Soil

• 🌍 New Alert System for Indigenous Communities

• 🤖 Combo Gel Protects From Fire

MEDICAL ACHIEVEMENTS 🧬

International Trial for Lung Cancer Vaccine Begins

• A promising lung cancer vaccine is about to be tested

• The trial will span across seven countries

• It is expected to cure lung cancer and prevent relapse

Scientists across the world are working hard to fight one of the most difficult diseases of our time - cancer. There are a lot of variants to this disease, one of them is lung cancer. It accounts for about 1.8 million deaths every year worldwide, with the most common form being non-small cell lung cancer or NSCLC. The problem with cancer is that, even though our bodies are very well adapted to recognize foreign cells and fight against them, in the case of tumors, that does not happen. But cheer up! We have some great news!

Experts at BioNTech have created a new vaccine that looks extremely promising. Similarly to the COVID-19 vaccine, this one also relies on messenger RNA (mRNA). Scientists use mRNA to present the immune system with NSCLC tumor markers, teaching the patient’s body to target cancer cells. 

The researchers are so confident in the efficacy of this treatment that they started a massive vaccine trial in seven countries: the UK, the US, Germany, Hungary, Poland, Spain, and Turkey. The testing will involve 130 patients, regardless if they have just been diagnosed or already received treatment such as surgery, radiation, or chemotherapy. But that’s not all. Scientists believe this treatment will have long-term effects and prevent cancer from reappearing! Let’s hope the trial goes as planned and that the doctors can apply the treatment to other forms of cancer as well!

Become a paying subscriber of Good News Premium to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

• • Good News every Monday & Friday!
• • Uplifting news from various fields such as the medical, technological, environmental, and scientific world!
• • We keep it simple, short, and easy to understand!
• • Lots of smiles and positive feelings!